Application Area: Treatment of vestibular disorders, including Ménière’s disease (as part of approved formulations)
Betahistine Mesilate is an API used in the management of vestibular disorders and inner-ear related conditions. It is supplied as a crystalline powder suitable for solid oral dosage forms. The API acts as a histamine analogue and is commonly incorporated into formulations targeting vertigo and balance disorders. Protective pharmaceutical-grade packaging is used to minimize exposure to light and moisture. Storage at controlled room temperature supports product stability.
As a leading distribution partner, Molkem Chemicals supports the reliable supply of products aligned with industry quality standards and regulatory expectations. Each product is delivered as per agreed specifications and is supported by standard documentation, including COA, SDS, and TDS. Where required, additional stability data and regulatory assistance can be extended through our technical team.